Facebook tracking pixel
J45.20
ICD-10-CM
Asthma Mild Intermittent

Find information on mild intermittent asthma diagnosis, clinical documentation, and medical coding. Learn about managing mild intermittent asthma, including treatment options and identifying symptoms. This resource offers guidance for healthcare professionals on accurately documenting and coding mild intermittent asthma for optimal patient care and accurate medical records. Explore resources related to the diagnosis of mild intermittent asthma and related healthcare terminology.

Also known as

Mild Intermittent Asthma

Diagnosis Snapshot

Key Facts
  • Definition : Infrequent asthma symptoms (2 or fewer days/week) and nighttime awakenings (2 or fewer nights/month).
  • Clinical Signs : Wheezing, coughing, shortness of breath, chest tightness. Symptoms are typically mild and infrequent.
  • Common Settings : Primary care, urgent care, pulmonology. Diagnosis often involves spirometry testing.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC J45.20 Coding
J45.20-J45.21

Mild intermittent asthma

Asthma with infrequent, mild symptoms.

J45-J46

Asthma and status asthmaticus

Covers various types and severities of asthma.

J00-J99

Diseases of the respiratory system

Encompasses a wide range of respiratory conditions.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is asthma confirmed?

  • Yes

    Is asthma mild intermittent?

  • No

    Do not code asthma. Review diagnosis and consider alternative diagnoses.

Code Comparison

Related Codes Comparison

When to use each related code

Description
Mild intermittent asthma with infrequent symptoms.
Mild persistent asthma with regular but manageable symptoms.
Moderate persistent asthma with daily symptoms impacting activity levels.

Documentation Best Practices

Documentation Checklist
  • Asthma diagnosis: ICD-10-CM code (e.g., J45.20)
  • Document symptom frequency: <2 days/week
  • Nighttime awakenings: <2x/month
  • Short-acting beta-agonist use: <2 days/week
  • Normal FEV1 between exacerbations

Coding and Audit Risks

Common Risks
  • Unspecified Asthma Severity

    Coding asthma as mild intermittent without sufficient documentation to rule out other severities can lead to undercoding and lost revenue.

  • Comorbidity Overlooked

    Mild intermittent asthma may coexist with other respiratory conditions like allergies or rhinitis, potentially impacting coding accuracy and reimbursement.

  • Exacerbation Miscoding

    Failing to distinguish between routine asthma care and treatment for acute exacerbations can result in inaccurate coding and improper payment.

Mitigation Tips

Best Practices
  • Asthma action plan: Identify triggers, use SABA prn.
  • Document symptom frequency, severity, and duration for accurate ICD-10 coding (J45.20).
  • Regular spirometry for objective assessment and CDI.
  • Patient education on medication adherence and inhaler technique.
  • Monitor and document response to therapy for compliance with quality measures.

Clinical Decision Support

Checklist
  • Verify intermittent symptoms: <2 days/week, <2 nights/month
  • FEV1/FVC normal, FEV1 >80% predicted
  • Symptom-free between exacerbations
  • Assess and document asthma triggers
  • Confirm diagnosis per GINA guidelines

Reimbursement and Quality Metrics

Impact Summary
  • Asthma Mild Intermittent reimbursement: ICD-10-CM J45.20, optimize medical billing for maximum payment.
  • Coding accuracy impact: Correct J45.20 coding crucial for accurate hospital reporting and revenue cycle.
  • Quality metrics: Asthma management programs impact HEDIS measures, affecting hospital quality scores.
  • Hospital reporting: Precise asthma diagnosis coding (J45.20) improves data accuracy for public health reporting.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How to differentiate mild intermittent asthma from other causes of intermittent wheezing in children?

A: Differentiating mild intermittent asthma from other causes of intermittent wheezing, such as viral bronchiolitis, bronchiectasis, or foreign body aspiration, in children can be challenging. Key indicators for mild intermittent asthma include episodic wheezing and coughing, particularly at night or with exercise, and a positive response to bronchodilators. Symptoms typically occur less than twice a week and nighttime awakenings less than twice a month. A detailed patient history focusing on symptom triggers (e.g., allergens, viral infections, exercise) is crucial. Physical examination might reveal normal findings between episodes. Spirometry might be normal between exacerbations but may show improvement after bronchodilator administration during an episode. Consider performing allergy testing to identify potential triggers. For children with recurrent wheezing, consider referral to a pulmonologist for further evaluation, including more specialized tests like methacholine challenge testing to assess airway hyperresponsiveness. Explore how a stepwise approach to asthma diagnosis can help rule out other respiratory conditions.

Q: What are the best evidence-based first-line treatment options for mild intermittent asthma in adults with comorbidities?

A: For adults with mild intermittent asthma and comorbidities like hypertension or gastroesophageal reflux disease (GERD), treatment should consider potential drug interactions and disease-specific contraindications. As-needed short-acting beta2-agonists (SABAs), like albuterol, remain the first-line treatment for symptom relief during exacerbations. However, frequent SABA use might indicate inadequate control and necessitate a step-up in therapy. For patients with comorbidities influenced by beta-agonist use, such as certain cardiovascular conditions, anticholinergic inhalers can be considered. Managing comorbidities effectively is essential; for example, optimizing GERD treatment can improve asthma control. Educate patients about identifying and avoiding triggers, including allergens and irritants, and emphasizing proper inhaler technique. Consider implementing a shared decision-making approach to tailor treatment to the individual patient's needs and preferences, considering both asthma and comorbidity management. Learn more about comorbidity management in asthma patients.

Quick Tips

Practical Coding Tips
  • Code J45.20 for Mild Intermittent Asthma
  • Document symptom frequency for J45.20
  • Verify necessity of medications documented
  • Check for exacerbations requiring additional codes

Documentation Templates

Patient presents with symptoms consistent with mild intermittent asthma.  The patient reports episodic wheezing, shortness of breath (dyspnea), chest tightness, and cough, particularly at night or early in the morning.  These asthma symptoms occur less than twice per week and are typically brief, lasting minutes to hours.  Symptom-free periods between exacerbations are observed.  Nighttime awakenings due to asthma occur less than twice per month.  Lung function tests, including FEV1 (forced expiratory volume in one second) and FEV1FVC ratio (forced expiratory volume in one second to forced vital capacity), are generally normal between episodes and fall within normal limits during the patient encounter today.  The patient denies any current respiratory distress.  No signs of status asthmaticus are present.  Based on symptom frequency and severity, along with normal lung function between exacerbations, a diagnosis of mild intermittent asthma is made.  The patient was educated on asthma triggers, including allergens, respiratory infections, and exercise.  An asthma action plan was reviewed, emphasizing the importance of recognizing early warning signs and utilizing a short-acting beta-agonist (SABA) rescue inhaler as needed for symptom relief.  The patient was also advised on the importance of regular follow-up care for asthma management and monitoring.  No long-term control medications are indicated at this time given the intermittent nature of symptoms.  Patient education materials on asthma control and prevention were provided.  Follow-up appointment scheduled in three months to reassess asthma control and adjust treatment plan if needed.  ICD-10 code J45.20 (Asthma, unspecified, uncomplicated) is assigned.
Asthma Mild Intermittent - AI-Powered ICD-10 Documentation